Get the Stockscreener App
80.28
4.56%
-3.84
Globus Medical Inc stock is traded at $80.28, with a volume of 3.19M.
It is down -4.56% in the last 24 hours and down -13.13% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
See More
Previous Close:
$84.12
Open:
$82.82
24h Volume:
3.19M
Relative Volume:
3.04
Market Cap:
$10.93B
Revenue:
$2.48B
Net Income/Loss:
$91.51M
P/E Ratio:
119.82
EPS:
0.67
Net Cash Flow:
$293.77M
1W Performance:
-4.35%
1M Performance:
-13.13%
6M Performance:
+15.36%
1Y Performance:
+45.96%
1-Day Range:
$79.50
$82.82
1-Week Range:
$79.50
$85.50
52-Week Range:
$49.33
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
80.28 | 10.93B | 2.48B | 91.51M | 293.77M | 0.67 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
Globus Medical Reports Record Sales and Strong Growth in 2024 - MSN
Is Globus Medical, Inc. (NYSE:GMED) Trading At A 32% Discount? - Yahoo Finance
Globus Medical, Inc. (NYSE:GMED) Q4 2024 Earnings Call Transcript - Insider Monkey
Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips - Yahoo Finance Australia
Globus Medical’s net sales increase 6.6% to USD 657.3M in Q4 2024 - Medical Buyer
Globus Medical Reports Outstanding Q4 2024 Financial ResultsNews and Statistics - IndexBox, Inc.
Globus Medical Inc (GMED) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Globus Medical Reports Strong 2024 Financial Performance - TipRanks
Globus Medical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Globus Medical (GMED) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Globus Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Globus Medical: Q4 Revenue Tops Forecast - Nasdaq
Globus Medical: Q4 Earnings Snapshot - Thehour.com
Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
GLOBUS MEDICAL Earnings Results: $GMED Reports Quarterly Earnings - Nasdaq
Globus Medical: Q4 Earnings Snapshot -February 20, 2025 at 05:05 pm EST - Marketscreener.com
GLOBUS MEDICAL INC SEC 10-K Report - TradingView
Globus Medical’s (NYSE:GMED) Q4 Sales Beat Estimates - Yahoo Finance
Globus Medical Q4 Non-GAAP EPS, Net Sales Increase -February 20, 2025 at 04:53 pm EST - Marketscreener.com
Globus Medical Reports Fourth Quarter and Full Year 2024 Results - TradingView
Globus Medical (GMED) Q4 Earnings: What To Expect - MSN
Globus Medical (GMED) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - MSN
Globus Medical to Announce Q4 and Full-Year 2024 Financial Results - MSN
Globus Medical's SWOT analysis: stock outlook amid acquisition and FDA warning - MSN
Globus Medical Pays 38% Premium for Nevro - https://ryortho.com/
bLong Financial LLC Buys Shares of 4,800 Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Paradice Investment Management LLC Sells 157,430 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Pembroke Management LTD Has $46.31 Million Stock Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? - MSN
AlphaCentric Advisors LLC Takes $2 Million Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Banque Pictet & Cie SA Decreases Stake in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical: Some Caution After Its Deal For Nevro (NYSE:GMED) - Seeking Alpha
Globus Medical To Buy Nevro In $250 Million Deal - Pulse 2.0
Empowered Funds LLC Buys Shares of 77,432 Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain? - MSN
Lightrock Netherlands B.V. Acquires New Holdings in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical (GMED) to Release Quarterly Earnings on Thursday - MarketBeat
Cambiar Investors LLC Sells 3,380 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Angeles Wealth Management LLC Makes New $247,000 Investment in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical (NYSE:GMED) Raised to "Buy" at StockNews.com - MarketBeat
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Vaughan Nelson Investment Management L.P. Trims Stock Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Audubon’s Globus Medical Makes Game-Changing Acquisition - MSN
GMEDGlobus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results - br.ADVFN.com
Stephens Investment Management Group LLC Sells 124,490 Shares of Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):